PAM
MEDP icon

Panagora Asset Management’s Medpace MEDP Stock Holding History

Panagora Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95M Sell
15,010
-45,018
-75% -$20.8M 0.02% 371
2026
Q1 		$28.8M Buy
60,028
+5,364
+10% +$2.75M 0.11% 185
2025
Q4 		$30.7M Buy
+54,664
New +$31M 0.11% 177
2025
Q1 		– Sell
-20,089
Closed -$6.67M – 1159
2024
Q4 		$6.67M Buy
20,089
+4,188
+26% +$1.42M 0.03% 300
2024
Q3 		$5.31M Buy
15,901
+159
+1% +$60.4K 0.03% 338
2024
Q2 		$6.48M Sell
15,742
-10
-0.1% -$3.96K 0.03% 276
2024
Q1 		$6.37M Buy
15,752
+88
+0.6% +$30.9K 0.03% 297
2023
Q4 		$4.8M Sell
15,664
-521
-3% -$141K 0.03% 325
2023
Q3 		$3.92M Buy
+16,185
New +$4.14M 0.02% 354
2022
Q2 		– Sell
-8,401
Closed -$1.37M – 1552
2022
Q1 		$1.37M Buy
8,401
+8
+0.1% +$1.32K 0.01% 808
2021
Q4 		$1.83M Sell
8,393
-362
-4% -$75.8K 0.01% 680
2021
Q3 		$1.66M Hold
8,755
– – 0.01% 761
2021
Q2 		$1.55M Sell
8,755
-2,491
-22% -$430K 0.01% 799
2021
Q1 		$1.84M Buy
11,246
+120
+1% +$18.4K 0.01% 768
2020
Q4 		$1.55M Sell
11,126
-109
-1% -$13.7K 0.01% 798
2020
Q3 		$1.25M Sell
11,235
-26,698
-70% -$3.09M 0.01% 820
2020
Q2 		$3.53M Hold
37,933
– – 0.02% 497
2020
Q1 		$2.78M Sell
37,933
-15,245
-29% -$1.32M 0.02% 499
2019
Q4 		$4.47M Hold
53,178
– – 0.02% 516
2019
Q3 		$4.47M Hold
53,178
– – 0.02% 490
2019
Q2 		$3.48M Hold
53,178
– – 0.02% 616
2019
Q1 		$3.14M Sell
53,178
-914
-2% -$54.6K 0.01% 674
2018
Q4 		$2.86M Sell
54,092
-927
-2% -$50.9K 0.01% 641
2018
Q3 		$3.3M Sell
55,019
-3,341
-6% -$183K 0.01% 662
2018
Q2 		$2.51M Buy
58,360
+3,322
+6% +$134K 0.01% 790
2018
Q1 		$1.92M Sell
55,038
-2,531
-4% -$92.5K 0.01% 891
2017
Q4 		$2.09M Buy
57,569
+700
+1% +$24.5K 0.01% 860
2017
Q3 		$1.81M Buy
56,869
+51,969
+1,061% +$1.59M 0.01% 899
2017
Q2 		$142K Buy
+4,900
New +$137K ﹤0.01% 1773

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Panagora Asset Management's MEDP Position: Q2 2026 in Review

Panagora Asset Management reduced its Medpace (MEDP) stake by 75% in Q2 2026, selling an estimated $20.8M and leaving 15,010 shares worth $7.95M. The position accounts for 0.02% of the portfolio, ranked #371.

Panagora Asset Management first reported a position in MEDP in Q2 2017 and has held it in 29 quarters since. The position peaked at $30.7M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Panagora Asset Management held 15,010 shares of Medpace worth $7.95M as of Q2 2026.
  • Panagora Asset Management sold 45,018 Medpace shares in Q2 2026, an estimated $20.8M.
  • Medpace made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #371 holding.
  • Panagora Asset Management first reported a position in Medpace in Q2 2017 and has held it in 29 quarters since.
  • Panagora Asset Management's Medpace position peaked at $30.7M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.